Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2025-12-17 @ 3:37 PM
Study NCT ID:
NCT06435702
Status:
None
Last Update Posted:
2024-05-30 00:00:00
First Post:
2024-05-26 00:00:00
Brief Title:
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study
Sponsor:
Peking University Third Hospital
Organization:
Peking University Third Hospital
Organization Data
Organization:
Peking University Third Hospital
Class:
OTHER
Study ID:
LM2023526
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peking University Third Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bayer | INDUSTRY |